Group 1 - The core viewpoint of the news is the performance and holdings of the ICBC Frontier Medical Stock C fund, which has seen a recent decline in net value and varying returns over different time frames [1] - As of July 2, 2025, the latest net value of ICBC Frontier Medical Stock C is 2.9870 yuan, reflecting a decrease of 2.48% [1] - The fund's performance over the past month shows a return of -0.53%, ranking 804 out of 898 in its category; over the past six months, it has achieved a return of 18.53%, ranking 133 out of 878; and since the beginning of the year, it has returned 16.32%, ranking 134 out of 878 [1] Group 2 - The top ten holdings of ICBC Frontier Medical Stock C account for a total of 59.05%, with significant positions in companies such as Heng Rui Pharmaceutical (10.11%), Kelun Pharmaceutical (8.01%), and WuXi AppTec (7.72%) [1] - The fund was established on November 23, 2020, and as of March 31, 2025, it has a total scale of 1.38 billion yuan, managed by fund manager Zhao Bei [1]
7月2日工银前沿医疗股票C净值下跌2.48%，近1个月累计下跌0.53%
Sou Hu Cai Jing·2025-07-02 13:04